PHARMACEUTICAL FORMULATION COMPRISING PHOSPHATIDYLCHOLINE FOR THE TREATMENT OF ULCERATIVE COLITIS.

摘要

A pharmaceutical formulation, comprising a phosphatidylcholine product of formula (I), wherein R1 is the residue of a saturated or unsaturated fatty acid with 12-24 carbon atoms, and R2 is the residue of a saturated or unsaturated fatty acid with 12-24 carbon atoms, and wherein the phosphatidylcholine product (PC) contains the following amounts of fatty acids: 55 –72 linoleic acid; 10 –18 palmitic acid; 07 –15 oleic acid; 02 –08 linolenic acid; 02 –08 stearic acid, and at least one excipient for delayed release, can be used for the improved treatment of ulcerative colitis.